{"id":3535368,"date":"2022-02-11T10:04:31","date_gmt":"2022-02-11T15:04:31","guid":{"rendered":"https:\/\/www.merck.com\/?post_type=story&#038;p=3535368"},"modified":"2022-03-03T12:48:49","modified_gmt":"2022-03-03T17:48:49","slug":"merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial","status":"publish","type":"story","link":"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/","title":{"rendered":"\u2018I can tell my kids: You did something special\u2019"},"content":{"rendered":"\n<div id=\"mco-f1-article-hero-block_62015c269390b\" class=\"mco-f1-article-hero corporateberg-block\">\n    <div class=\"mco-f1-article-hero-content-container\">\n                    <small class=\"tagline\">Our people<\/small>\n        \n                    <h1>\u2018I can tell my kids: You did something special\u2019<\/h1>\n        \n                    <p>Merck scientist Angela Jablonski explains why she enrolled her children in a pediatric COVID-19 vaccine trial<\/p>\n            <\/div>\n\n    <div class=\"mco-f1-article-hero-date-container\">\n        <p class=\"mco-f1-article-hero-date text-descriptive\">February 11, 2022<\/p>\n\n        <div class=\"mco-f1-article-share-btn-container\">\n            <p class=\"text-descriptive\">Share this article<\/p>\n            <p><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/\" target=\"_blank\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n    <path fill=\"#00857C\" d=\"M6.023 16L6 9H3V6h3V4c0-2.7 1.672-4 4.08-4 1.153 0 2.144.086 2.433.124v2.821h-1.67c-1.31 0-1.563.623-1.563 1.536V6H13l-1 3H9.28v7H6.023z\" \/>\n<\/svg>\n<\/a><\/p>\n            <p><a href=\"https:\/\/twitter.com\/intent\/tweet?text=https%3A%2F%2Fwww.merck.com%2Fstories%2Fmerck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial%2F \u2018I can tell my kids: You did something special\u2019\" target=\"_blank\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n    <path fill=\"#00857C\" d=\"M16 3.5c-.6.3-1.2.4-1.9.5.7-.4 1.2-1 1.4-1.8-.6.4-1.3.6-2.1.8-.6-.6-1.5-1-2.4-1-1.7 0-3.2 1.5-3.2 3.3 0 .3 0 .5.1.7-2.7-.1-5.2-1.4-6.8-3.4-.3.5-.4 1-.4 1.7 0 1.1.6 2.1 1.5 2.7-.5 0-1-.2-1.5-.4 0 1.6 1.1 2.9 2.6 3.2-.3.1-.6.1-.9.1-.2 0-.4 0-.6-.1.4 1.3 1.6 2.3 3.1 2.3-1.1.9-2.5 1.4-4.1 1.4H0c1.5.9 3.2 1.5 5 1.5 6 0 9.3-5 9.3-9.3v-.4c.7-.5 1.3-1.1 1.7-1.8z\" \/>\n<\/svg>\n<\/a><\/p>\n            <p><a href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https%3A%2F%2Fwww.merck.com%2Fstories%2Fmerck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial%2F\" target=\"_blank\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n    <path fill=\"#00857C\" d=\"M15.205 0H.695C.299 0 0 .3 0 .7v14.7c0 .3.298.6.696.6h14.608c.398 0 .696-.3.696-.7V.7c-.1-.4-.398-.7-.795-.7zM4.671 13.6H2.385V6H4.77v7.6h-.1zM3.578 5c-.795 0-1.392-.7-1.392-1.4 0-.8.597-1.4 1.392-1.4.795 0 1.39.6 1.39 1.4-.098.7-.695 1.4-1.39 1.4zm9.938 8.6H11.13V9.9c0-.9 0-2-1.192-2-1.193 0-1.391 1-1.391 2v3.8H6.16V6h2.286v1c.298-.6 1.093-1.2 2.187-1.2 2.385 0 2.782 1.6 2.782 3.6v4.2h.1z\" \/>\n<\/svg>\n<\/a><\/p>\n            <p><a href=\"mailto:?&#038;subject=\u2018I can tell my kids: You did something special\u2019&#038;body=https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/ Merck scientist Angela Jablonski explains why she enrolled her children in a pediatric COVID-19 vaccine trial\" target=\"_blank\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n    <path fill=\"#00857C\" d=\"M16 5.7V14c0 .6-.4 1-1 1H1c-.6 0-1-.4-1-1V5.7l7.5 4.2c.28.14.72.14 1 0L16 5.7zM15 1c.6 0 1 .4 1 1v1.5L8 7.9 0 3.4V2c0-.6.4-1 1-1z\" \/>\n<\/svg>\n<\/a><\/p>\n        <\/div>\n    <\/div>\n\n    <div class=\"mco-f1-article-hero-image-container\">\n        <div class=\"mco-f1-article-image-parent \">\n            <picture>\n                <source media=\"(max-width: 767px)\" data-srcset=\"https:\/\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?resize=321,214\">\n                <source media=\"(min-width: 768px) and (max-width: 1279px)\" data-srcset=\"https:\/\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?resize=656,371\">\n                <source media=\"(min-width: 1280px)\" data-srcset=\"https:\/\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?resize=1188,672\">\n                <img\n                    data-src=\"https:\/\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?resize=1188,672\"\n                    alt=\"article hero thumbnail\"\n                    class=\"lazyload\"\n                    loading=\"lazy\"\n                \/>\n            <\/picture>\n\n                    <\/div>\n    <\/div>\n\n    <div class=\"mco-f1-article-hero-modal popup\" style=\"display: none;\">\n        <div class=\"popup-wrapper\">\n            <div class=\"mco-f1-article-hero-modal-content popup-content\">\n                \n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\n<p>Like many parents of young children, Angela Jablonski felt helpless and frustrated as COVID-19 vaccines rolled out for adults and older kids while little ones remained unprotected.<\/p>\n\n\n\n<p>\u201cIt felt like everyone was starting to get back to normal, especially over the summer, but people with younger kids were left in this limbo of what\u2019s safe and what isn\u2019t,\u201d said Jablonski, a Merck senior scientist with Global Regulatory Affairs &amp; Clinical Safety, as well as mom to Jack, 3, and Leo, 1.<\/p>\n\n\n\n<p>Two years into the pandemic, parents are still waiting for a COVID-19 vaccine for children 5 and under to be approved, and the Omicron surge has only intensified the toll on families.<\/p>\n\n\n\n<p>Jablonski, who lost a cousin to COVID-19 in December of 2020, just three months after Leo was born, ultimately decided that standing by was no longer an option. In the summer of 2021, she filled out an interest form for a pediatric vaccine clinical trial at Children\u2019s Hospital of Philadelphia (CHOP). By the fall, Leo and Jack were enrolled in a Phase 3 COVID-19 vaccine study for children ages 6 months to 5 years.<\/p>\n\n\n\n<p>\u201cIf you know someone who passed away from COVID-19, it can be difficult to move on and accept it, knowing that this virus changed your life in a permanent way,\u201d said Jablonski, adding that the death of her cousin, a frontline health care worker known for his kindness to patients, has left a deep wound in her family. \u201cThis was a way to honor my cousin and contribute to the science.\u201d<\/p>\n\n\n\n<h2>\u201cSomeone has to go first\u201d<\/h2>\n\n\n\n<p>Jablonski acknowledged that not all parents are eager to vaccinate their children against COVID-19 and said she and her husband faced some criticism over their decision to take part in a double-blind clinical trial (meaning that participants don&#8217;t know for sure whether they&#8217;re receiving the vaccine or a placebo). <\/p>\n\n\n\n<p>\u201cOne of the criticisms I got was, \u2018Oh my God, you\u2019re experimenting on your kids,\u2019\u201d she said. \u201cBut when you think about any major breakthrough in science, it takes a group of people to bring that medicine about for everyone. Someone has to go first.\u201d<\/p>\n\n\n\n<p>If anything, Jablonski said, participating in the study made her feel even more confident about vaccinating her children because they would be so closely monitored throughout the process. There are regular check-ins, medical exams and COVID tests, and Jablonski and her husband submit e-diary entries charting their children\u2019s progress.<\/p>\n\n\n\n<p>\u201cFor me, the people who really helped bring this about were the Phase 1 trial participants, where they\u2019re just checking if the vaccine is safe and picking the optimal dose,\u201d she said. \u201cIn my mind, those are some of the real heroes.\u201d<\/p>\n\n\n\n<div id=\"article-images-block-block_62016ecb9390d\" class=\"article-images-block-wrapper wrapper-story-narrow corporateberg-block mt-2 mb-2\">\n    <section class=\"article-images-block \">\n                    <div class=\"article-images-block-img-wrapper\">\n                <picture>\n                    <source media=\"(max-width: 767px)\" data-srcset=\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jabloski-with-sons.jpg?fit=1076%2C716&#038;ssl=1?resize=321,214\">\n                    <source media=\"(min-width: 768px) and (max-width: 1279px)\" data-srcset=\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jabloski-with-sons.jpg?fit=1076%2C716&#038;ssl=1?resize=227,151\">\n                    <source media=\"(min-width: 1280px)\" data-srcset=\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jabloski-with-sons.jpg?fit=1076%2C716&#038;ssl=1?resize=404,269\">\n                    <img\n                        data-src=\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jabloski-with-sons.jpg?fit=1076%2C716&#038;ssl=1?resize=404,269\"\n                        alt=\"Angela sitting with her sons\"\n                        class=\"lazyload\"\n                        loading=\"lazy\"\n                    \/>\n                <\/picture>\n                            <\/div>\n                \n                    <div class=\"article-images-block-img-wrapper\">\n                                    <picture>\n                        <source media=\"(max-width: 767px)\" data-srcset=\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jabloski-and-son.jpg?fit=1076%2C716&#038;ssl=1?resize=322,214\">\n                        <source media=\"(min-width: 768px) and (max-width: 1279px)\" data-srcset=\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jabloski-and-son.jpg?fit=1076%2C716&#038;ssl=1?resize=399,267\">\n                        <source media=\"(min-width: 1280px)\" data-srcset=\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jabloski-and-son.jpg?fit=1076%2C716&#038;ssl=1?resize=628,418\">\n                        <img\n                            data-src=\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jabloski-and-son.jpg?fit=1076%2C716&#038;ssl=1?resize=628,418\"\n                            alt=\"Angela and her son after the vaccine\"\n                            class=\"lazyload\"\n                            loading=\"lazy\"\n                        \/>\n                    <\/picture>\n                                            <\/div>\n                    <\/section>\n<\/div>\n\n\n<h2>A way of healing<\/h2>\n\n\n\n<p>Now three months into the vaccine clinical trial, Jablonski said the hardest part has been the blood draws \u2013 \u201cbecause, as you can imagine, a 1-year-old and a 3-year-old having their blood drawn isn\u2019t fun.\u201d<\/p>\n\n\n\n<p>Otherwise, the experience has been overwhelmingly positive, she said. The kids have become pros at taking COVID-19 tests, occasionally sleeping through the nose swabs, and Jack loves the superhero mask and teddy bear he got from the staff at CHOP.<\/p>\n\n\n\n<p>And, Jablonski adds, \u201cAs a scientist, it\u2019s incredible to see how it\u2019s done and to know that we\u2019re a part of that.\u201d<\/p>\n\n\n\n<p>When she thinks back to the earlier days of the pandemic \u2013&nbsp;worrying whether her husband would be allowed at the hospital during Leo\u2019s birth, being isolated with a new baby and toddler, and losing her cousin \u2013&nbsp;Jablonski feels fortunate to be where she is now.<\/p>\n\n\n\n<p>\u201cI did feel like my pregnancy and the first year of Leo\u2019s life was joyous, but there was a cloud over it, especially when my cousin passed away,\u201d she said. \u201cThis is almost like a way of healing and bringing something positive out of such a hard experience. And I can tell my kids: \u2018You guys did something special. We lost a lot, and it was really tough, but you helped bring about something good for other kids.\u2019\u201d<\/p>\n\n\n\n<h4>If you\u2019re interested in learning about Merck\u2019s COVID-19 clinical trials, visit <a href=\"https:\/\/merckcovidresearch.com\/\">MerckCovidResearch.com<\/a>. For information about other clinical trials, visit <a href=\"https:\/\/www.merckclinicaltrials.com\/\">MerckClinicalTrials.com<\/a>.<\/h4>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div id=\"mco-f3-more-stories-block-block_62016ba39390c\" class=\"mco-f3-more-stories-block negative corporateberg-block\">\n    <div class=\"mco-f3-stories-container\">\n        <small class=\"tagline\">Discover more stories<\/small>\n        <div class=\"mco-f3-stories-slider-container\">\n                                <div class=\"mco-f3-story\">\n                        <p><a href=\"https:\/\/www.merck.com\/stories\/key-takeaways-from-this-years-u-n-general-assembly\/\">Key takeaways from this year\u2019s U.N. General Assembly<\/a><\/p>\n                    <\/div>\n                                <div class=\"mco-f3-story\">\n                        <p><a href=\"https:\/\/www.merck.com\/stories\/this-leader-is-dedicated-to-developing-future-women-leaders\/\">This leader is dedicated to developing future women leaders<\/a><\/p>\n                    <\/div>\n                                <div class=\"mco-f3-story\">\n                        <p><a href=\"https:\/\/www.merck.com\/stories\/debunking-type-2-diabetes-misconceptions\/\">Debunking type 2 diabetes misconceptions<\/a><\/p>\n                    <\/div>\n                    <\/div>\n        <div class=\"mco-f3-stories-slider-controls-container slider-nav\">\n                                    <div class='slider-nav-item active'><\/div>\n                                            <div class='slider-nav-item '><\/div>\n                                            <div class='slider-nav-item '><\/div>\n                            <\/div>\n    <\/div>\n\n    <div class=\"mco-f3-content-container\">\n        <a class=\"btn secondary\" href=\"https:\/\/www.merck.com\/stories\">View all stories<\/a>\n    <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Like many parents of young children, Angela Jablonski felt helpless and frustrated as COVID-19 vaccines rolled out for adults and older kids while little ones remained unprotected. \u201cIt felt like everyone was starting to get back to normal, especially over the summer, but people with younger kids were left in this limbo of what\u2019s safe [&hellip;]<\/p>\n","protected":false},"featured_media":3535537,"template":"","meta":{"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"episode_type":"audio","audio_file":"","duration":"","filesize":"","date_recorded":"","explicit":"","block":"","filesize_raw":""},"tags":[303,262,163,175],"content_topic":[2],"admin_field":[],"series":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u2018I can tell my kids: You did something special\u2019 - Merck.com<\/title>\n<meta name=\"description\" content=\"Merck scientist Angela Jablonski explains why she enrolled her children in a pediatric COVID-19 vaccine trial\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u2018I can tell my kids: You did something special\u2019 - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Merck scientist Angela Jablonski explains why she enrolled her children in a pediatric COVID-19 vaccine trial\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-03T17:48:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1188\" \/>\n\t<meta property=\"og:image:height\" content=\"672\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.merck.com\/#website\",\"url\":\"https:\/\/www.merck.com\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.merck.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?fit=1188%2C672&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?fit=1188%2C672&ssl=1\",\"width\":1188,\"height\":672,\"caption\":\"Angela Jablonski and her family\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#webpage\",\"url\":\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/\",\"name\":\"\u2018I can tell my kids: You did something special\u2019 - Merck.com\",\"isPartOf\":{\"@id\":\"https:\/\/www.merck.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#primaryimage\"},\"datePublished\":\"2022-02-11T15:04:31+00:00\",\"dateModified\":\"2022-03-03T17:48:49+00:00\",\"description\":\"Merck scientist Angela Jablonski explains why she enrolled her children in a pediatric COVID-19 vaccine trial\",\"breadcrumb\":{\"@id\":\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Stories\",\"item\":\"https:\/\/www.merck.com\/stories-archive\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u2018I can tell my kids: You did something special\u2019\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u2018I can tell my kids: You did something special\u2019 - Merck.com","description":"Merck scientist Angela Jablonski explains why she enrolled her children in a pediatric COVID-19 vaccine trial","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/","og_locale":"en_US","og_type":"article","og_title":"\u2018I can tell my kids: You did something special\u2019 - Merck.com","og_description":"Merck scientist Angela Jablonski explains why she enrolled her children in a pediatric COVID-19 vaccine trial","og_url":"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/","og_site_name":"Merck.com","article_modified_time":"2022-03-03T17:48:49+00:00","og_image":[{"width":1188,"height":672,"url":"https:\/\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.merck.com\/#website","url":"https:\/\/www.merck.com\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.merck.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#primaryimage","inLanguage":"en-US","url":"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?fit=1188%2C672&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?fit=1188%2C672&ssl=1","width":1188,"height":672,"caption":"Angela Jablonski and her family"},{"@type":"WebPage","@id":"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#webpage","url":"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/","name":"\u2018I can tell my kids: You did something special\u2019 - Merck.com","isPartOf":{"@id":"https:\/\/www.merck.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#primaryimage"},"datePublished":"2022-02-11T15:04:31+00:00","dateModified":"2022-03-03T17:48:49+00:00","description":"Merck scientist Angela Jablonski explains why she enrolled her children in a pediatric COVID-19 vaccine trial","breadcrumb":{"@id":"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Stories","item":"https:\/\/www.merck.com\/stories-archive\/"},{"@type":"ListItem","position":2,"name":"\u2018I can tell my kids: You did something special\u2019"}]}]}},"episode_featured_image":"https:\/\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?w=1024","episode_player_image":"https:\/\/www.merck.com\/wp-content\/plugins\/seriously-simple-podcasting\/assets\/images\/no-album-art.png","download_link":false,"player_link":false,"audio_player":false,"episode_data":{"playerMode":"dark","subscribeUrls":{"apple_podcasts":{"key":"apple_podcasts","url":"","label":"Apple Podcasts","icon":"apple-podcasts.png"},"stitcher":{"key":"stitcher","url":"","label":"Stitcher","icon":"stitcher.png"},"google_podcasts":{"key":"google_podcasts","url":"","label":"Google Podcasts","icon":"google-podcasts.png"},"spotify":{"key":"spotify","url":"","label":"Spotify","icon":"spotify.png"}},"rssFeedUrl":"https:\/\/www.merck.com\/feed\/podcast","embedCode":"<blockquote class=\"wp-embedded-content\" data-secret=\"cOUCanuvjG\"><a href=\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/\">\u2018I can tell my kids: You did something special\u2019<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.merck.com\/stories\/merck-scientist-enrolls-children-in-pediatric-covid-19-vaccine-trial\/embed\/#?secret=cOUCanuvjG\" width=\"500\" height=\"350\" title=\"&#8220;\u2018I can tell my kids: You did something special\u2019&#8221; &#8212; Merck.com\" data-secret=\"cOUCanuvjG\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/*! This file is auto-generated *\/\n!function(c,d){\"use strict\";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},!c.wp.receiveEmbedMessage)if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var r,a,i,s=d.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=d.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=0;o<n.length;o++)n[o].style.display=\"none\";for(o=0;o<s.length;o++)if(r=s[o],e.source===r.contentWindow){if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(i=parseInt(t.value,10)))i=1e3;else if(~~i<200)i=200;r.height=i}if(\"link\"===t.message)if(a=d.createElement(\"a\"),i=d.createElement(\"a\"),a.href=r.getAttribute(\"src\"),i.href=t.value,i.host===a.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),d.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(!o){o=!0;for(var e,t,r,a=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),i=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),s=d.querySelectorAll(\"iframe.wp-embedded-content\"),n=0;n<s.length;n++){if(!(r=(t=s[n]).getAttribute(\"data-secret\")))r=Math.random().toString(36).substr(2,10),t.src+=\"#?secret=\"+r,t.setAttribute(\"data-secret\",r);if(a||i)(e=t.cloneNode(!0)).removeAttribute(\"security\"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:\"ready\",secret:r},\"*\")}}}}(window,document);\n<\/script>\n"},"extended_data":{"featured_image":"https:\/\/www.merck.com\/wp-content\/uploads\/sites\/5\/2022\/02\/jablonski-family-featured-image.jpg?w=1024","acf_fields":{"mco_page_tracking_data":"var utag_data = { \r\npage_type : \"disease awareness and education\",\r\npage_audience : \"employees\",\r\npage_therapeuticarea : \"infectious diseases\",\r\npage_reputationdriver : \"citizenship\",\r\npage_contenttopic : \"our people\",\r\npage_secondarycontenttag : \"our people, clinical trials, infectious diseases, vaccines\",\r\npage_theme : \"vaccines\",\r\npage_milestone : \"none\"\r\n} ;","show_section":true,"story_one_selection":"select","related_content_item_one":{"ID":2773913,"post_author":"4","post_date":"2021-01-25 12:02:35","post_date_gmt":"2021-01-25 12:02:35","post_content":"<!-- wp:acf\/hero-block {\n    \"id\": \"block_5e9608aea9d61\",\n    \"name\": \"acf\\\/hero-block\",\n    \"data\": {\n        \"mco_hero_block_tagline_text\": \"\",\n        \"_mco_hero_block_tagline_text\": \"mco_hero_block_tagline_text\",\n        \"mco_hero_block_ttle\": \"Our COVID-19 efforts\",\n        \"_mco_hero_block_ttle\": \"mco_hero_block_title\",\n        \"mco_hero_block_description\": \"We\u2019ve been committed to advancing an effective response to the COVID-19 pandemic since it was first recognized. As a company with a long legacy of research in vaccines and <a href=\\\"https:\\\/\\\/www.merck.com\\\/research\\\/infectious-diseases\\\/\\\">infectious diseases<\\\/a>, it is our responsibility to mobilize our scientific expertise and experience to help address the pandemic.\",\n        \"_mco_hero_block_description\": \"mco_hero_block_description\",\n        \"mco_hero_block_image_url\": 3068296,\n        \"_mco_hero_block_image_url\": \"mco_hero_block_image_url\",\n        \"mco_hero_block_image_small_url\": \"\",\n        \"_mco_hero_block_image_small_url\": \"mco_hero_block_image_small_url\",\n        \"mco_hero_block_button_cta\": \"\",\n        \"_mco_hero_block_button_cta\": \"mco_hero_block_button_cta\",\n        \"video_hosting_selection\": \"select\",\n        \"_video_hosting_selection\": \"hero_video_type\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\"\n} \/-->\n\n<!-- wp:heading {\"level\":4} -->\n<h4>Since the start of the pandemic, we have been focused on contributing our scientific expertise to help address COVID-19.<\/h4>\n<!-- \/wp:heading -->\n\n<!-- wp:columns {\"className\":\"border-top-1\"} -->\n<div class=\"wp-block-columns border-top-1\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3} -->\n<h3>Advancing our investigational oral antiviral COVID-19 medicine<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph -->\n<p>In collaboration with Ridgeback Biotherapeutics, we are advancing our research and development efforts for our investigational oral antiviral COVID-19 medicine. We believe we\u2019re making a meaningful impact on the pandemic through our programs. <\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>We are working with regulatory authorities around the world to make our oral antiviral treatment available globally. We are also continuing our research and development efforts to investigate broader uses of our oral antiviral medicine.<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:columns {\"className\":\"border-top-1\"} -->\n<div class=\"wp-block-columns border-top-1\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\">Our commitment to access <\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph -->\n<p>To <a href=\"https:\/\/www.merck.com\/stories\/accelerating-global-access\/\">accelerate&nbsp;broad&nbsp;global access<\/a>,&nbsp;our&nbsp;comprehensive&nbsp;supply and access&nbsp;approach includes producing millions of courses of our investigational oral antiviral candidate through our global network, which includes manufacturing sites in nine countries across three continents.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Additionally, we have entered into advance purchase and supply agreements with the governments of several countries worldwide and are currently in discussions with additional governments. We have signed&nbsp;<a href=\"https:\/\/www.merck.com\/news\/amid-humanitarian-crisis-in-india-merck-announces-voluntary-licensing-agreements-with-five-indian-generics-manufacturers-to-accelerate-and-expand-global-access-to-molnupiravir-an-investigational-ora\/\">voluntary license agreements&nbsp;<\/a>with multiple established Indian generic manufacturers and the&nbsp;<a href=\"https:\/\/www.merck.com\/news\/the-medicines-patent-pool-mpp-and-merck-enter-into-license-agreement-for-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-to-increase-broad-access-in-low-and-middle-income-countri\/\">Medicines Patent Pool<\/a>&nbsp;to facilitate the availability of generic versions of our treatment option to more than 100 low- and middle-income countries. We\u2019ve also allocated up to 3 million courses of therapy to UNICEF for low- and middle-income countries. <\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Through our licensing agreements with generics manufacturers and the Medicines Patent Pool, more than 3 million courses of generic therapy have been delivered to more than 15 low- and middle-income markets included in the licenses through March 2022.<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:columns {\"className\":\"border-top-1\"} -->\n<div class=\"wp-block-columns border-top-1\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\">Partnering to manufacture and supply Johnson &amp; Johnson\u2019s vaccines<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph -->\n<p>We are proud to lend our expertise and capacity&nbsp;to support the manufacturing and supply&nbsp;of Johnson &amp; Johnson\u2019s COVID-19 vaccine. We believe the vaccines developed by the research-based pharmaceutical industry are the most important first-line of defense for the prevention of COVID-19.<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:columns {\"className\":\"border-top-1\"} -->\n<div class=\"wp-block-columns border-top-1\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\">COVID-19 clinical trials<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph -->\n<p>Our clinical development program includes several preclinical and early-phase studies, and two Phase 3 trials, one of which is currently evaluating our antiviral in the prevention setting:<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:list -->\n<ul><li>MOVe-AHEAD: &nbsp;evaluating our oral antiviral candidate for post-exposure prophylaxis in adults who reside in the same household as someone with symptomatic, laboratory-confirmed COVID-19 who has not had those signs and symptoms for more than five days.<\/li><\/ul>\n<!-- \/wp:list -->\n\n<!-- wp:paragraph -->\n<p>Learn more about our COVID-19 research and <a href=\"https:\/\/merckcovidresearch.com\/\">find a clinical trial<\/a>.<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Recent COVID-19 news:<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph {\"className\":\"border-bottom-1\"} -->\n<p class=\"border-bottom-1\">June 7, 2022 - <a href=\"https:\/\/www.merck.com\/news\/merck-and-ridgeback-announce-new-data-for-investigational-lagevrio-molnupiravir-from-phase-3-move-out-study\/\">Merck and Ridgeback Announce New Data For Investigational LAGEVRIO\u2122 (molnupiravir) From Phase 3 MOVe-OUT Study<\/a><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph {\"className\":\"border-bottom-1\"} -->\n<p class=\"border-bottom-1\">May 12, 2022 - <a href=\"https:\/\/www.merck.com\/news\/merck-announces-commitments-to-pandemic-response-as-part-of-2nd-global-covid-19-summit\/\">Merck Announces Commitments to Pandemic Response as Part of 2nd Global COVID-19 Summit<\/a><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph {\"className\":\"border-bottom-1\"} -->\n<p class=\"border-bottom-1\">April 1, 2022 - <a href=\"https:\/\/www.merck.com\/news\/merck-and-ridgeback-to-present-data-demonstrating-that-treatment-with-lagevrio-molnupiravir-was-associated-with-more-rapid-elimination-of-infectious-sars-cov-2-than-placebo\/\">Merck and Ridgeback to Present Data Demonstrating That Treatment With LAGEVRIO\u2122 (molnupiravir) Was Associated With More Rapid Elimination of Infectious SARS-CoV-2 Than Placebo<\/a><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:acf\/b6-accordion-list {\n    \"id\": \"block_62e97bfd798c0\",\n    \"name\": \"acf\\\/b6-accordion-list\",\n    \"data\": {\n        \"mco_b6_accordion_list_tagline\": \"\",\n        \"_mco_b6_accordion_list_tagline\": \"mco_b6_accordion_list_tagline_6947uhf9ywhuj\",\n        \"mco_b6_accordion_list_title\": \"\",\n        \"_mco_b6_accordion_list_title\": \"mco_b6_accordion_list_title_6947uhf9ywhuj\",\n        \"mco_b6_accordion_list_row_0_mco_b6_accordion_list_row_summary\": \"View more\",\n        \"_mco_b6_accordion_list_row_0_mco_b6_accordion_list_row_summary\": \"mco_b6_accordion_list_row_summary_6947uhf9ywhuj\",\n        \"mco_b6_accordion_list_row_0_mco_b6_accordion_list_row_details\": \"<p class=\\\"border-bottom-1\\\">February 19, 2022 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-statement-on-clinical-trial-of-heteros-generic-molnupiravir\\\/\\\">Merck and Ridgeback Statement on Clinical Trial of Hetero\u2019s Generic Molnupiravir<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">February 8, 2022 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states\\\/\\\">Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">January 28, 2022 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgebacks-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-demonstrated-activity-against-omicron-variant-in-in-vitro-studies\\\/\\\">Merck and Ridgeback\u2019s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">January 18, 2022 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-announce-supply-agreement-with-unicef-for-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine\\\/\\\">Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">December 24, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgebacks-molnupiravir-an-investigational-oral-antiviral-covid-19-treatment-receives-special-approval-for-emergency-in-japan\\\/\\\">Merck and Ridgeback\u2019s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">December 23, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgebacks-molnupiravir-receives-u-s-fda-emergency-use-authorization-for-the-treatment-of-high-risk-adults-with-mild-to-moderate-covid-19\\\/\\\">Merck and Ridgeback\u2019s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">December 22, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-announce-u-k-government-to-purchase-additional-1-75-million-courses-of-molnupiravir\\\/\\\">Merck and Ridgeback Announce U.K. Government to Purchase Additional 1.75 Million Courses of Molnupiravir<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">December 16, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-announce-publication-of-phase-3-study-of-molnupiravir-an-investigational-oral-antiviral-covid-19-treatment-in-the-new-england-journal-of-medicine\\\/\\\">Merck and Ridgeback Announce Publication of Phase 3 Study of Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, in the New England Journal of Medicine<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">November 30, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-statement-on-positive-fda-advisory-committee-vote-for-investigational-oral-antiviral-molnupiravir-for-treatment-of-mild-to-moderate-covid-19-in-high-risk-adults\\\/\\\">Merck and Ridgeback Statement on Positive FDA Advisory Committee Vote for Investigational Oral Antiviral Molnupiravir for Treatment of Mild to Moderate COVID-19 in High Risk Adults<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">November 26, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-biotherapeutics-provide-update-on-results-from-move-out-study-of-molnupiravir-an-investigational-oral-antiviral-medicine-in-at-risk-adults-with-mild-to-moderate-covid-19\\\/\\\">Merck and Ridgeback Biotherapeutics Provide Update on Results from MOVe-OUT Study of Molnupiravir, an Investigational Oral Antiviral Medicine, in At Risk Adults With Mild-to-Moderate COVID-19<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">November 17, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-to-present-phase-3-data-for-molnupiravir-an-investigational-oral-covid-19-antiviral-medicine-at-american-society-of-tropical-medicine-and-hygiene-astmh-2021-annual-meeting\\\/\\\">Merck and Ridgeback to Present Phase 3 Data for Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, at American Society of Tropical Medicine and Hygiene (ASTMH) 2021 Annual Meeting<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">November 10, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-announce-japanese-government-to-purchase-1-6-million-courses-of-molnupiravir-an-investigational-oral-covid-19-antiviral-medicine-upon-authorization-or-approval\\\/\\\">Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, Upon Authorization or Approval<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">November 9, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-announce-u-s-government-to-purchase-1-4-million-additional-courses-of-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-mild-to-moderate-covid-19-in-a\\\/\\\">Merck and Ridgeback Announce U.S. Government to Purchase 1.4 Million Additional Courses of Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of Mild-to-Moderate COVID-19 in At Risk Adults<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">November 4, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgebacks-molnupiravir-an-oral-covid-19-antiviral-medicine-receives-first-authorization-in-the-world\\\/\\\">Merck and Ridgeback\u2019s Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">October 27, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/the-medicines-patent-pool-mpp-and-merck-enter-into-license-agreement-for-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-to-increase-broad-access-in-low-and-middle-income-countri\\\/\\\">The Medicines Patent Pool (MPP) and Merck Enter Into License Agreement for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, to Increase Broad Access in Low- and Middle-Income Countries<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">October 25, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-announce-initiation-of-a-rolling-review-by-the-european-medicines-agency-for-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-covid-19-in-adults\\\/\\\">Merck and Ridgeback Announce Initiation of a Rolling Review by the European Medicines Agency for Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of COVID-19 in Adults<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">October 11, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgeback-announce-submission-of-emergency-use-authorization-application-to-the-u-s-fda-for-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-mild-to-moderate-c\\\/\\\">Merck and Ridgeback Announce Submission of Emergency Use Authorization Application to the U.S. FDA for Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of Mild-to-Moderate COVID-19 in At Risk Adults<\\\/a><\\\/p>\\r\\n<p class=\\\"border-bottom-1\\\">October 1, 2021 -\u00a0<a href=\\\"https:\\\/\\\/www.merck.com\\\/news\\\/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat\\\/\\\">Merck and Ridgeback\u2019s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study<\\\/a><\\\/p>\",\n        \"_mco_b6_accordion_list_row_0_mco_b6_accordion_list_row_details\": \"mco_b6_accordion_list_row_details_6947uhf9ywhuj\",\n        \"mco_b6_accordion_list_row_0_mco_b6_accordion_list_row_image\": \"\",\n        \"_mco_b6_accordion_list_row_0_mco_b6_accordion_list_row_image\": \"mco_b6_accordion_list_row_image_6947uhf9ywhuj\",\n        \"mco_b6_accordion_list_row_0_mco_b6_accordion_list_row_open\": \"0\",\n        \"_mco_b6_accordion_list_row_0_mco_b6_accordion_list_row_open\": \"mco_b6_accordion_list_row_open_6947uhf9ywhuj\",\n        \"mco_b6_accordion_list_row\": 1,\n        \"_mco_b6_accordion_list_row\": \"mco_b6_accordion_list_row_6947uhf9ywhuj\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\",\n    \"className\": \"mt-2 mb-2\"\n} \/-->\n\n<!-- wp:paragraph -->\n<p><a class=\"btn secondary\" href=\"https:\/\/www.merck.com\/media\/our-investigational-covid-19-antiviral\/\">Media Library<\/a><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:spacer {\"height\":50} -->\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<!-- \/wp:spacer -->\n\n<!-- wp:heading {\"textAlign\":\"center\"} -->\n<h2 class=\"has-text-align-center\">Stepping up to combat COVID-19 as a company<\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:acf\/title-block {\n    \"id\": \"block_62bb047e66333\",\n    \"name\": \"acf\\\/title-block\",\n    \"data\": {\n        \"title\": \" \",\n        \"_title\": \"mco_title_block_title\",\n        \"description\": \"<p style=\\\"text-align: center;\\\">The COVID-19 pandemic continues to be a scientific and global health challenge. As a company with a legacy of research in infectious diseases, we have a responsibility to keep our employees safe.<\\\/p>\",\n        \"_description\": \"mco_title_block_description\",\n        \"content_label\": \"\",\n        \"_content_label\": \"mco_title_block_content_label\",\n        \"cta_one\": \"\",\n        \"_cta_one\": \"mco_title_block_cta_one\",\n        \"cta_two\": \"\",\n        \"_cta_two\": \"mco_title_block_cta_two\",\n        \"image\": \"\",\n        \"_image\": \"mco_title_block_image\"\n    },\n    \"align\": \"center\",\n    \"mode\": \"edit\",\n    \"className\": \"mt-2 mb-2\"\n} \/-->\n\n<!-- wp:columns {\"className\":\"border-top-1\"} -->\n<div class=\"wp-block-columns border-top-1\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\">Protecting our employees and their families<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"className\":\"mt-2\"} -->\n<p class=\"mt-2\">Throughout the COVID-19 pandemic, we have prioritized the health, safety and well-being of our employees and their families. Extensive steps have been taken to ensure that all of our work sites, including manufacturing plants and labs, are as safe as possible. We have supported COVID-19 vaccination, diagnosis and treatment,&nbsp;focused on physical, mental, social and financial well-being and provided resources to improve our working environment.&nbsp;<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:columns {\"className\":\"border-top-1\"} -->\n<div class=\"wp-block-columns border-top-1\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\">Giving back<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph -->\n<p>We are committed to supporting our health care providers and our communities. Where possible, our employees around the world have been helping, including contributing volunteer services and donations to support both local and global responses. In response to the COVID-19 pandemic, we changed our volunteer policy to support employees with nursing and other medical backgrounds.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>We recognize the need for additional health care professionals \u2014 including doctors, nurses and medical laboratory technicians \u2014 throughout a pandemic. That\u2019s why in March 2020, we launched a program to enable our medically trained employees to volunteer their time to aid their communities while maintaining their base pay. Learn more about <a href=\"https:\/\/www.merck.com\/company-overview\/esg\/philanthropy\/\">philanthropy at Merck<\/a>, and check out our annual <a href=\"https:\/\/www.merck.com\/company-overview\/esg\/\">Environmental, Social &amp; Governance (ESG) report<\/a>.<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:acf\/feature-stories-block {\n    \"id\": \"block_5e960f8ea9d6b\",\n    \"name\": \"acf\\\/feature-stories-block\",\n    \"data\": {\n        \"title\": \"COVID-19 Stories \",\n        \"_title\": \"mco_feature_stories_block_title\",\n        \"description\": \"Our work in the fight against COVID-19 reaches across all corners of our company, our personal lives and our communities, where many of our medically trained employees have volunteered their time.\",\n        \"_description\": \"mco_feature_stories_block_description\",\n        \"cta_one\": {\n            \"title\": \"View our stories\",\n            \"url\": \"https:\\\/\\\/www.merck.com\\\/stories\\\/\",\n            \"target\": \"\"\n        },\n        \"_cta_one\": \"mco_feature_stories_block_cta_one\",\n        \"card_count\": \"4\",\n        \"_card_count\": \"mco_feature_stories_count\",\n        \"show_tags\": \"0\",\n        \"_show_tags\": \"mco_feature_stories_block_show_tags\",\n        \"content_selection\": \"manual\",\n        \"_content_selection\": \"mco_featured_stories_block_content_selection\",\n        \"story_one\": 2806739,\n        \"_story_one\": \"mco_featured_stories_block_story_one\",\n        \"story_two\": 2845654,\n        \"_story_two\": \"mco_featured_stories_block_story_two\",\n        \"story_three\": 2934338,\n        \"_story_three\": \"mco_featured_stories_block_story_three\",\n        \"story_four\": 2804790,\n        \"_story_four\": \"mco_featured_stories_block_story_four\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\",\n    \"className\": \"mt-2\"\n} \/-->","post_title":"COVID-19","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"covid-19","to_ping":"","pinged":"","post_modified":"2022-08-29 12:01:34","post_modified_gmt":"2022-08-29 16:01:34","post_content_filtered":"","post_parent":47,"guid":"https:\/\/www.merck.com\/?page_id=2773913","menu_order":1,"post_type":"page","post_mime_type":"","comment_count":"0","filter":"raw"},"story_two_selection":"select","related_content_item_two":{"ID":244447,"post_author":"183","post_date":"2020-04-03 18:04:48","post_date_gmt":"2020-04-03 18:04:48","post_content":"<!-- wp:acf\/hero-block {\n    \"id\": \"block_5e9df0177465f\",\n    \"name\": \"acf\\\/hero-block\",\n    \"data\": {\n        \"mco_hero_block_tagline_text\": \"\",\n        \"_mco_hero_block_tagline_text\": \"mco_hero_block_tagline_text\",\n        \"mco_hero_block_ttle\": \"Vaccines\",\n        \"_mco_hero_block_ttle\": \"mco_hero_block_title\",\n        \"mco_hero_block_description\": \"Our work in vaccines focuses on making certain diseases a thing of the past.\",\n        \"_mco_hero_block_description\": \"mco_hero_block_description\",\n        \"mco_hero_block_image_url\": 4852,\n        \"_mco_hero_block_image_url\": \"mco_hero_block_image_url\",\n        \"mco_hero_block_image_small_url\": \"\",\n        \"_mco_hero_block_image_small_url\": \"mco_hero_block_image_small_url\",\n        \"mco_hero_block_button_cta\": \"\",\n        \"_mco_hero_block_button_cta\": \"mco_hero_block_button_cta\",\n        \"video_hosting_selection\": \"select\",\n        \"_video_hosting_selection\": \"hero_video_type\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\"\n} \/-->\n\n<!-- wp:acf\/title-block {\n    \"id\": \"block_5e9df04d74660\",\n    \"name\": \"acf\\\/title-block\",\n    \"data\": {\n        \"title\": \"Vaccines are one of the greatest public health success stories in history\",\n        \"_title\": \"mco_title_block_title\",\n        \"description\": \"Without vaccines, the world would have lost more sons, daughters, moms and grandpas - more future teachers, builders, doctors and inventors - more people than an entire country the size of the U.S.\",\n        \"_description\": \"mco_title_block_description\",\n        \"content_label\": \"\",\n        \"_content_label\": \"mco_title_block_content_label\",\n        \"cta_one\": \"\",\n        \"_cta_one\": \"mco_title_block_cta_one\",\n        \"cta_two\": \"\",\n        \"_cta_two\": \"mco_title_block_cta_two\",\n        \"image\": \"\",\n        \"_image\": \"mco_title_block_image\"\n    },\n    \"align\": \"center\",\n    \"mode\": \"edit\"\n} \/-->\n\n<!-- wp:acf\/title-block {\n    \"id\": \"block_5e9df07074661\",\n    \"name\": \"acf\\\/title-block\",\n    \"data\": {\n        \"title\": \"Our work in vaccines\",\n        \"_title\": \"mco_title_block_title\",\n        \"description\": \"\",\n        \"_description\": \"mco_title_block_description\",\n        \"content_label\": \"\",\n        \"_content_label\": \"mco_title_block_content_label\",\n        \"cta_one\": \"\",\n        \"_cta_one\": \"mco_title_block_cta_one\",\n        \"cta_two\": \"\",\n        \"_cta_two\": \"mco_title_block_cta_two\",\n        \"image\": \"\",\n        \"_image\": \"mco_title_block_image\"\n    },\n    \"align\": \"center\",\n    \"mode\": \"preview\",\n    \"className\": \"pull-up-stats negative mb-2\"\n} \/-->\n\n<!-- wp:group {\"className\":\"stat-group mb-2\"} -->\n<div class=\"wp-block-group stat-group mb-2\"><!-- wp:acf\/statistics-block {\n    \"id\": \"block_5e9df4ff74662\",\n    \"name\": \"acf\\\/statistics-block\",\n    \"data\": {\n        \"stat_statistic\": \"11\",\n        \"_stat_statistic\": \"stat_block_statistic\",\n        \"stat_caption\": \"In the U.S., we make vaccines for\",\n        \"_stat_caption\": \"stat_block_caption\",\n        \"stat_description\": \"of the 17 diseases on the CDC's recommended immunization schedules\",\n        \"_stat_description\": \"stat_block_description\",\n        \"stat_cta\": \"\",\n        \"_stat_cta\": \"stat_block_cta_link\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\"\n} \/-->\n\n<!-- wp:acf\/statistics-block {\n    \"id\": \"block_5e9df50374663\",\n    \"name\": \"acf\\\/statistics-block\",\n    \"data\": {\n        \"stat_statistic\": \"~190M\",\n        \"_stat_statistic\": \"stat_block_statistic\",\n        \"stat_caption\": \"We distributed\",\n        \"_stat_caption\": \"stat_block_caption\",\n        \"stat_description\": \"doses around the world in 2019\",\n        \"_stat_description\": \"stat_block_description\",\n        \"stat_cta\": \"\",\n        \"_stat_cta\": \"stat_block_cta_link\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\"\n} \/--><\/div>\n<!-- \/wp:group -->\n\n<!-- wp:columns {\"className\":\"border-top-1\"} -->\n<div class=\"wp-block-columns border-top-1\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3,\"className\":\"mr-2 mt-2\"} -->\n<h3 class=\"mr-2 mt-2\">Experience in vaccines<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"className\":\"mt-2\"} -->\n<p class=\"mt-2\">We've been discovering, developing and delivering vaccines to help prevent disease around the world for over 100 years.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>It is no secret that inventing and developing vaccines is complex, time intensive and carries no guarantees.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>To keep pace with the ever-evolving disease landscape, we continue to research candidates to address significant unmet needs.<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:columns {\"className\":\"border-top-1\"} -->\n<div class=\"wp-block-columns border-top-1\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3,\"className\":\"mr-2 mt-2\"} -->\n<h3 class=\"mr-2 mt-2\">Collaboration and progress in vaccines<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"className\":\"mt-2\"} -->\n<p class=\"mt-2\">It takes active collaboration by our teams who partner with governments, academic researchers and non-government organizations around the world.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Our work in researching and producing vaccines is guided by science and fueled by human need.<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:columns {\"className\":\"border-top-1 border-bottom-1\"} -->\n<div class=\"wp-block-columns border-top-1 border-bottom-1\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3,\"className\":\"mr-2 mt-2\"} -->\n<h3 class=\"mr-2 mt-2\">Programs in vaccines<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"className\":\"mt-2\"} -->\n<p class=\"mt-2\">Inspired by the rich legacy and innovative spirit of the long-time scientist, Dr. Maurice Hilleman, we are proud to be engaging with the global health community through the MSD-Wellcome Trust Hilleman Laboratories. The mission of the Laboratories is to pursue innovation in vaccine science and technology that helps make access to vaccines more affordable and equitable in lower-income markets. <\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:acf\/title-block {\n    \"id\": \"block_5e9e024e74665\",\n    \"name\": \"acf\\\/title-block\",\n    \"data\": {\n        \"title\": \"There are many aspects of our work in vaccines\",\n        \"_title\": \"mco_title_block_title\",\n        \"description\": \"Sharing our stories is a privilege. Let's keep inspiring each other until these global health challenges become a thing of the past.\",\n        \"_description\": \"mco_title_block_description\",\n        \"content_label\": \"\",\n        \"_content_label\": \"mco_title_block_content_label\",\n        \"cta_one\": {\n            \"title\": \"Check out our unique perspectives\",\n            \"url\": \"https:\\\/\\\/www.merck.com\\\/stories\\\/\",\n            \"target\": \"\"\n        },\n        \"_cta_one\": \"mco_title_block_cta_one\",\n        \"cta_two\": \"\",\n        \"_cta_two\": \"mco_title_block_cta_two\",\n        \"image\": \"\",\n        \"_image\": \"mco_title_block_image\"\n    },\n    \"align\": \"center\",\n    \"mode\": \"edit\"\n} \/-->\n\n<!-- wp:acf\/featured-stories-block-e1 {\n    \"id\": \"block_5e9e033274666\",\n    \"name\": \"acf\\\/featured-stories-block-e1\",\n    \"data\": {\n        \"content_selection\": \"manual\",\n        \"_content_selection\": \"mco_featured_stories_e1_block_content_selection\",\n        \"story_one\": 2770489,\n        \"_story_one\": \"mco_featured_stories_e1_block_story_one\",\n        \"story_two\": 2774686,\n        \"_story_two\": \"mco_featured_stories_e1_block_story_two\",\n        \"story_three\": 692396,\n        \"_story_three\": \"mco_featured_stories_e1_block_story_three\",\n        \"story_four\": 2777798,\n        \"_story_four\": \"mco_featured_stories_e1_block_story_four\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\"\n} \/-->\n\n<!-- wp:acf\/content-block {\n    \"id\": \"block_5e9e034474667\",\n    \"name\": \"acf\\\/content-block\",\n    \"data\": {\n        \"negative_style\": \"0\",\n        \"_negative_style\": \"content_block_negative\",\n        \"content_selection\": \"static\",\n        \"_content_selection\": \"content_selction_method\",\n        \"content_block_image\": 451758,\n        \"_content_block_image\": \"content_block_image\",\n        \"content_block_heading\": \"Our commitment is unwavering\",\n        \"_content_block_heading\": \"content_block_heading\",\n        \"content_block_body\": \"As long as there are people still in hospitals, doctors desperate to add years to their lives, preventable diseases that threaten people's health, we will be here: fighting with all we have to deliver more, sooner.\",\n        \"_content_block_body\": \"content_block_body\",\n        \"content_block_cta\": {\n            \"title\": \"Learn more\",\n            \"url\": \"https:\\\/\\\/www.merck.com\\\/patients\\\/\",\n            \"target\": \"\"\n        },\n        \"_content_block_cta\": \"content_block_cta\",\n        \"content_block_optional_cta\": \"\",\n        \"_content_block_optional_cta\": \"content_block_optional_cta\",\n        \"content_block_optional_tag\": \"\",\n        \"_content_block_optional_tag\": \"content_block_optional_tag\",\n        \"content_block_video\": \"\",\n        \"_content_block_video\": \"content_block_video\",\n        \"content_media_position\": \"left\",\n        \"_content_media_position\": \"content_media_position\",\n        \"brightcove_account_id\": \"\",\n        \"_brightcove_account_id\": \"bright_cove_account_id\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\"\n} \/-->","post_title":"Vaccines","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"vaccines","to_ping":"","pinged":"","post_modified":"2022-09-14 20:15:29","post_modified_gmt":"2022-09-15 00:15:29","post_content_filtered":"","post_parent":47,"guid":"https:\/\/www.merck.com\/?page_id=244447","menu_order":0,"post_type":"page","post_mime_type":"","comment_count":"0","filter":"raw"},"story_three_selection":"select","related_content_item_three":{"ID":243421,"post_author":"183","post_date":"2020-04-03 16:10:09","post_date_gmt":"2020-04-03 16:10:09","post_content":"<!-- wp:acf\/hero-block {\n    \"id\": \"block_610d46af7e8dd\",\n    \"name\": \"acf\\\/hero-block\",\n    \"data\": {\n        \"mco_hero_block_tagline_text\": \"\",\n        \"_mco_hero_block_tagline_text\": \"mco_hero_block_tagline_text\",\n        \"mco_hero_block_ttle\": \"Clinical trials\",\n        \"_mco_hero_block_ttle\": \"mco_hero_block_title\",\n        \"mco_hero_block_description\": \"Clinical trials help find new treatments to help save and improve lives.\\r\\n\\r\\nOur progress is due in large part to the important and tough scientific questions we set out to answer with our trials and collaborations.\",\n        \"_mco_hero_block_description\": \"mco_hero_block_description\",\n        \"mco_hero_block_image_url\": 2991730,\n        \"_mco_hero_block_image_url\": \"mco_hero_block_image_url\",\n        \"mco_hero_block_image_small_url\": \"\",\n        \"_mco_hero_block_image_small_url\": \"mco_hero_block_image_small_url\",\n        \"mco_hero_block_button_cta\": {\n            \"title\": \"Find a trial\",\n            \"url\": \"http:\\\/\\\/merckclinicaltrials.com\",\n            \"target\": \"_blank\"\n        },\n        \"_mco_hero_block_button_cta\": \"mco_hero_block_button_cta\",\n        \"video_hosting_selection\": \"select\",\n        \"_video_hosting_selection\": \"hero_video_type\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\"\n} \/-->\n\n<!-- wp:acf\/title-block {\n    \"id\": \"block_610d478f7e8de\",\n    \"name\": \"acf\\\/title-block\",\n    \"data\": {\n        \"title\": \"What is a clinical trial?\",\n        \"_title\": \"mco_title_block_title\",\n        \"description\": \"Clinical trials are research studies with volunteers designed to learn more about how\\r\\nour bodies respond to drugs or other treatments. We are grateful to the thousands of volunteers who participate in our clinical trials \u2013 making this all possible.\",\n        \"_description\": \"mco_title_block_description\",\n        \"content_label\": \"\",\n        \"_content_label\": \"mco_title_block_content_label\",\n        \"cta_one\": {\n            \"title\": \"View \\\"From trial to treatment\\\" infographic\",\n            \"url\": \"https:\\\/\\\/www.merck.com\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2021\\\/04\\\/ClinicalTrialsInfographic.pdf\",\n            \"target\": \"_blank\"\n        },\n        \"_cta_one\": \"mco_title_block_cta_one\",\n        \"cta_two\": \"\",\n        \"_cta_two\": \"mco_title_block_cta_two\",\n        \"image\": \"\",\n        \"_image\": \"mco_title_block_image\"\n    },\n    \"align\": \"center\",\n    \"mode\": \"edit\"\n} \/-->\n\n<!-- wp:acf\/content-block {\n    \"id\": \"block_5ebb12d9d87a3\",\n    \"name\": \"acf\\\/content-block\",\n    \"data\": {\n        \"negative_style\": \"0\",\n        \"_negative_style\": \"content_block_negative\",\n        \"content_selection\": \"static\",\n        \"_content_selection\": \"content_selction_method\",\n        \"content_block_image\": 2803121,\n        \"_content_block_image\": \"content_block_image\",\n        \"content_block_heading\": \"There are clinical trials in progress\",\n        \"_content_block_heading\": \"content_block_heading\",\n        \"content_block_body\": \"Our medical advances can only happen through the efforts of many people, especially the patients who volunteer for clinical trials. They are our partners in research.\",\n        \"_content_block_body\": \"content_block_body\",\n        \"content_block_cta\": {\n            \"title\": \"Find a trial\",\n            \"url\": \"https:\\\/\\\/www.merckclinicaltrials.com\\\/\",\n            \"target\": \"_blank\"\n        },\n        \"_content_block_cta\": \"content_block_cta\",\n        \"content_block_optional_cta\": {\n            \"title\": \"Merck COVID-19 research\",\n            \"url\": \"https:\\\/\\\/merckcovidresearch.com\\\/\",\n            \"target\": \"\"\n        },\n        \"_content_block_optional_cta\": \"content_block_optional_cta\",\n        \"content_block_optional_tag\": \"\",\n        \"_content_block_optional_tag\": \"content_block_optional_tag\",\n        \"content_block_video\": \"\",\n        \"_content_block_video\": \"content_block_video\",\n        \"content_media_position\": \"left\",\n        \"_content_media_position\": \"content_media_position\",\n        \"brightcove_account_id\": \"\",\n        \"_brightcove_account_id\": \"bright_cove_account_id\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\"\n} \/-->\n\n<!-- wp:acf\/content-block {\n    \"id\": \"block_61d4bf583e260\",\n    \"name\": \"acf\\\/content-block\",\n    \"data\": {\n        \"negative_style\": \"0\",\n        \"_negative_style\": \"content_block_negative\",\n        \"content_selection\": \"static\",\n        \"_content_selection\": \"content_selction_method\",\n        \"content_block_image\": 3422257,\n        \"_content_block_image\": \"content_block_image\",\n        \"content_block_heading\": \"Policies and perspectives\",\n        \"_content_block_heading\": \"content_block_heading\",\n        \"content_block_body\": \"We are committed to disclosing balanced, complete and accurate information about our registered clinical trials of marketed products, regardless of outcome.\\r\\n\\r\\n<a href=\\\"https:\\\/\\\/trialstransparency.merckclinicaltrials.com\\\/policies-perspectives.aspx\\\" target=\\\"_blank\\\" rel=\\\"noopener\\\">Learn more<\\\/a> about our clinical trials policies and perspectives.\",\n        \"_content_block_body\": \"content_block_body\",\n        \"content_block_cta\": \"\",\n        \"_content_block_cta\": \"content_block_cta\",\n        \"content_block_optional_cta\": \"\",\n        \"_content_block_optional_cta\": \"content_block_optional_cta\",\n        \"content_block_optional_tag\": \"\",\n        \"_content_block_optional_tag\": \"content_block_optional_tag\",\n        \"content_block_video\": \"\",\n        \"_content_block_video\": \"content_block_video\",\n        \"content_media_position\": \"right\",\n        \"_content_media_position\": \"content_media_position\",\n        \"brightcove_account_id\": \"\",\n        \"_brightcove_account_id\": \"bright_cove_account_id\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\",\n    \"className\": \"mb-2\"\n} \/-->\n\n<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column {\"width\":\"32%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:32%\"><!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\">Expanded Access Programs (EAP)<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mr-2\"} -->\n<h3 class=\"mr-2\"><\/h3>\n<!-- \/wp:heading --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"className\":\"mt-2\"} -->\n<p class=\"mt-2\">Participation in clinical trials should be the primary route by which patients get access to investigational medicines, and contribute to the collection of safety and efficacy data needed to support regulatory approval worldwide. For patients with a serious or life-threatening disease who are ineligible or unable to participate in a clinical trial, use of an expanded access program may be an option.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><a class=\"btn secondary\" target=\"_blank\" href=\"https:\/\/trialstransparency.merckclinicaltrials.com\/pdf\/ACCESS-TO-INVESTIGATIONAL-MEDICINES.pdf\">Learn more<\/a> about Expanded Access Programs (EAP)<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:acf\/featured-banner-block {\n    \"id\": \"block_5ebb1c00d87a6\",\n    \"name\": \"acf\\\/featured-banner-block\",\n    \"data\": {\n        \"mco_featured_banner_negative\": \"1\",\n        \"_mco_featured_banner_negative\": \"mco_featured_banner_negative_294ytohe\",\n        \"image\": 2253728,\n        \"_image\": \"mco_featured_banner_block_image\",\n        \"title\": \"Diversity in clinical trials\",\n        \"_title\": \"mco_featured_banner_block_title\",\n        \"description\": \"We strive to reduce health care disparities by achieving diversity in U.S. clinical trials.\",\n        \"_description\": \"mco_featured_banner_block_description\",\n        \"content_label\": \"\",\n        \"_content_label\": \"mco_featured_banner_block_content_label\",\n        \"cta_one\": \"\",\n        \"_cta_one\": \"mco_featured_banner_block_cta_one\",\n        \"cta_two\": {\n            \"title\": \"Learn more about diversity in clinical trials\",\n            \"url\": \"https:\\\/\\\/www.merck.com\\\/research-and-products\\\/diversity-in-clinical-trials\\\/\",\n            \"target\": \"\"\n        },\n        \"_cta_two\": \"mco_featured_banner_block_cta_two\",\n        \"cta_three\": \"\",\n        \"_cta_three\": \"mco_featured_banner_block_cta_three\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\",\n    \"className\": \"mb-2 mt-2\"\n} \/-->\n\n<!-- wp:acf\/feature-stories-block {\n    \"id\": \"block_5e9f15644a9f4\",\n    \"name\": \"acf\\\/feature-stories-block\",\n    \"data\": {\n        \"title\": \"Patient volunteers are our heroes \",\n        \"_title\": \"mco_feature_stories_block_title\",\n        \"description\": \"We strive to create clinical trials as diverse as the patients we serve. See the stories behind our work.\",\n        \"_description\": \"mco_feature_stories_block_description\",\n        \"cta_one\": {\n            \"title\": \"View our stories\",\n            \"url\": \"https:\\\/\\\/www.merck.com\\\/tag\\\/clinical-trials\\\/\",\n            \"target\": \"\"\n        },\n        \"_cta_one\": \"mco_feature_stories_block_cta_one\",\n        \"card_count\": \"4\",\n        \"_card_count\": \"mco_feature_stories_count\",\n        \"show_tags\": \"0\",\n        \"_show_tags\": \"mco_feature_stories_block_show_tags\",\n        \"content_selection\": \"manual\",\n        \"_content_selection\": \"mco_featured_stories_block_content_selection\",\n        \"story_one\": 2778325,\n        \"_story_one\": \"mco_featured_stories_block_story_one\",\n        \"story_two\": 2783226,\n        \"_story_two\": \"mco_featured_stories_block_story_two\",\n        \"story_three\": 2808449,\n        \"_story_three\": \"mco_featured_stories_block_story_three\",\n        \"story_four\": 3008665,\n        \"_story_four\": \"mco_featured_stories_block_story_four\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\",\n    \"className\": \"mt-2 mb-2\"\n} \/-->\n\n<!-- wp:acf\/content-block {\n    \"id\": \"block_5ebb1cecd87a7\",\n    \"name\": \"acf\\\/content-block\",\n    \"data\": {\n        \"negative_style\": \"0\",\n        \"_negative_style\": \"content_block_negative\",\n        \"content_selection\": \"static\",\n        \"_content_selection\": \"content_selction_method\",\n        \"content_block_image\": 365117,\n        \"_content_block_image\": \"content_block_image\",\n        \"content_block_heading\": \"Our commitment to patients is unwavering\",\n        \"_content_block_heading\": \"content_block_heading\",\n        \"content_block_body\": \"As long as there are patients still in hospitals, doctors and nurses desperate to add years to the lives of their patients and a world where treatments aren't accessible to all, we will be here: fighting with all we have to deliver more, sooner.\",\n        \"_content_block_body\": \"content_block_body\",\n        \"content_block_cta\": {\n            \"title\": \"See how we can help\",\n            \"url\": \"https:\\\/\\\/www.merck.com\\\/patients\\\/\",\n            \"target\": \"\"\n        },\n        \"_content_block_cta\": \"content_block_cta\",\n        \"content_block_optional_cta\": \"\",\n        \"_content_block_optional_cta\": \"content_block_optional_cta\",\n        \"content_block_optional_tag\": \"\",\n        \"_content_block_optional_tag\": \"content_block_optional_tag\",\n        \"content_block_video\": \"\",\n        \"_content_block_video\": \"content_block_video\",\n        \"content_media_position\": \"left\",\n        \"_content_media_position\": \"content_media_position\",\n        \"brightcove_account_id\": \"\",\n        \"_brightcove_account_id\": \"bright_cove_account_id\"\n    },\n    \"align\": \"\",\n    \"mode\": \"edit\"\n} \/-->","post_title":"Clinical trials","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"clinical-trials","to_ping":"","pinged":"","post_modified":"2022-06-23 15:09:56","post_modified_gmt":"2022-06-23 19:09:56","post_content_filtered":"","post_parent":47,"guid":"https:\/\/www.merck.com\/?page_id=243421","menu_order":4,"post_type":"page","post_mime_type":"","comment_count":"0","filter":"raw"},"scroll-to-top":false,"subheader_title":"Merck scientist Angela Jablonski explains why she enrolled her children in a pediatric COVID-19 vaccine trial","secondary_image":false,"video_hosting_selection":"youtube","youtube_url":"","primary_cta":"Read more","secondary_cta":""}},"_links":{"self":[{"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/story\/3535368"}],"collection":[{"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/story"}],"about":[{"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/types\/story"}],"version-history":[{"count":33,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/story\/3535368\/revisions"}],"predecessor-version":[{"id":3566632,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/story\/3535368\/revisions\/3566632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/media\/3535537"}],"wp:attachment":[{"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/media?parent=3535368"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/tags?post=3535368"},{"taxonomy":"Content Topic","embeddable":true,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/content_topic?post=3535368"},{"taxonomy":"Admin Field","embeddable":true,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/admin_field?post=3535368"},{"taxonomy":"series","embeddable":true,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/series?post=3535368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}